LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 27.49 27.76 1071 1723 0.6215 0.8465
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 27.49 27.76 1119 1723 0.6494 0.8602
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 27.49 27.76 1146 1723 0.6651 0.8676
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 27.49 27.76 1246 1723 0.7231 0.8940
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 27.49 27.76 1415 1723 0.8212 0.9349
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 27.49 27.76 1499 1723 0.8699 0.9538
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 29.19 27.76 1098 1863 0.5893 0.8331
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 29.19 27.76 1139 1863 0.6113 0.8442
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 29.19 27.76 1189 1863 0.6382 0.8573
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 29.19 27.76 1275 1863 0.6843 0.8788
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 29.19 27.76 1518 1863 0.8148 0.9336
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 29.19 27.76 1589 1863 0.8529 0.9482
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 30.90 27.76 1182 2032 0.5816 0.8324
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 30.90 27.76 1216 2032 0.5983 0.8408
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 30.90 27.76 1247 2032 0.6136 0.8483
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 30.90 27.76 1322 2032 0.6505 0.8659
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 30.90 27.76 1560 2032 0.7676 0.9164
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 30.90 27.76 1617 2032 0.7956 0.9275
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 32.60 27.76 1215 2235 0.5434 0.8163
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 32.60 27.76 1249 2235 0.5586 0.8243
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 32.60 27.76 1329 2235 0.5944 0.8423
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 32.60 27.76 1385 2235 0.6195 0.8543
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 32.60 27.76 1639 2235 0.7331 0.9043
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 32.60 27.76 1694 2235 0.7577 0.9142
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 34.30 27.76 1244 2449 0.5078 0.8009
MN20160318_Q01
G09